Proteomics Market | Size, Share, Growth and Industry Analysis

The global proteomics market size was valued at USD 24,361million in 2017 and is expected to reach USD 72,444 million by 2025, growing at a CAGR of 14.5% during the forecast period.

Proteomics is the study of the structure and functions of proteins that are used in drug discovery, diagnosis, and treatment of diseases. A proteome is never constant as it differs from one cell to another with time. Proteomics is used to evaluate the rate of protein production, the interaction of proteins with one another, the involvement of proteins in metabolic pathways, and the modification of proteins. Structural proteomics is used to identify the structure of protein complexes, while functional proteomics is used for characterizing the protein‐protein interactions to demonstrate protein functions.

Get Detailed Analysis of COVID-19 Impact on Proteomics Market @ https://reports.valuates.com/request/sample/ALLI-Auto-1A97/Proteomics_Market

Proteomics finds extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis, which have escalated the growth of the proteomics market in the past few years. With increase in awareness regarding the benefits of personalized medicines, companies and government organizations have increased their R&D expenditure on the development of proteomics.

Proteomics is the study of structure and functions of proteins. After the advent of genomics and transcriptomics, proteomics was the next step in the study of biological systems. It is a complex study when compared to genomics, as an organism's genome is constant, while the proteome differs with cells and time.

The global proteomics market is segmented into instruments, reagents, and services. Based on technology, the instruments segment is further divided into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. In the year 2015, protein microarrays accounted for the highest market share of instruments markets followed by spectrometry. In the reagents segment, immunoassays dominated the market in 2015, followed by spectroscopy and microarray reagents. On the basis of applications, the market is segmented in drug discovery, disease diagnosis, and others. Drug discovery was the largest application of proteomics in 2015. Geographically, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. In the year 2015, North America accounted for highest market share, owing to higher popularity of the technology, high cost of instruments, and high funding from the government and organizations such as National Institutes of Health (NIH) and National Science Foundation (NSF). Asia-Pacific is expected to witness fastest growth rate during the study period, owing to increase in government and corporate funding for R&D.

View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-1A97/proteomics

Over the past few years, the most important strategy followed by the leading companies was mergers & acquisitions. For instance, Thermo Fisher Scientific acquired Affymetrix Inc. (May 2016), and Life Technologies (February 2014) and Merck & Co., Inc. acquired Sigma-Aldrich (November 2015).

Furthermore, the global proteomics market trends are analyzed through the region vertical. B region, North America is anticipated to occupy the largest share in 2025, owing to heavy funding by various organizations and increase in adoption of agreements & collaborations. Moreover, rise in R&D investments is anticipated to facilitate the market growth during the forecast period.
Increase in competition and continuous technological advancements have led to enhancements in the product portfolio; hence, product development is one of the key developmental strategies adopted by the market players in the global proteomics market.

For instance, in June 2018, Bruker Corporation introduced a broad line of mass spectrometry products and workflows at the ASMS (American Society for Mass Spectrometry) conference. Likewise, in March 2017, ThermoFisher Scientific, Inc. launched iXR Raman Spectrometer. This new product was designed for rapid and accurate chemical and structural analysis. Furthermore, in January 2019, Waters Corporation introduced the BioAccord System, a liquid chromatography-mass spectrometry (LC-MS) solution that is anticipated to expand access to high-resolution time-of-flight mass spectrometry capabilities to more scientists Considerable increase has been witnessed in acquisitions and collaborations in the global proteomics industry. For instance, in June 2018, Waters Corporation acquired the exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and the Purdue Research Foundation (PRF). Similarly, in February 2017, Thermo Fisher Scientific, Inc. acquired Finesse Solutions, based in California, a leader in development of scalable control automation systems and software for bioproduction. This business was expected to integrate in Thermo Fisher’s Life Sciences Solutions Segment to optimize bioproduction workflow. Moreover, in June 2018, Thermo Scientific and Evosep collaborated to develop and promote robust, high-throughput workflows for clinical proteomics at the 66th Conference on Mass Spectrometry and Allied Topics.

The key companies profiled in the report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.

By Component

o Instruments
o Microarray
o Spectrometry
o Mass Spectrometry
o NMR Spectrometry
o X-ray Crystallography
o Chromatography
o HPLC Systems
o Ion Chromatography
o Affinity Chromatography
o Supercritical Fluid Chromatography
o Electrophoresis
o Surface Plasmon Resonance
o Protein Fractionation Reagents
o Reagents
o Microarray
o Spectroscopy
o X-ray Crystallography
o Chromatography
o Electrophoresis
o Immunoassay
o Protein Fractionation Reagents
o Services

By Application

o Drug Discovery
o Disease Diagnosis
o Others

Valuates Reports
sales@valuates.com
For U.S. Toll Free Call +1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp : +91-9945648335

Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Linkedin - https://in.linkedin.com/company/valuatesreports
Facebook - https://www.facebook.com/valuatesreports/

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources

This release was published on openPR.